In men who are overweight or obese, adding testosterone therapy reduced glucose intolerance/T2DM
Wittert G, Bracken K, Robledo KP, et al. Lancet Diabetes Endocrinol. 2021;9:32-45. 33338415.
Saved in:
| Published in | Annals of internal medicine Vol. 174; no. 5; p. JC54 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
United States
01.05.2021
|
| Online Access | Get more information |
Cover
Loading…
| Summary: | Wittert G, Bracken K, Robledo KP, et al.
Lancet Diabetes Endocrinol. 2021;9:32-45. 33338415. |
|---|---|
| ISSN: | 1539-3704 |
| DOI: | 10.7326/ACPJ202105180-054 |